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Abstract
The circulating recombinant form (CRF) 07_BC is the most prevalent HIV-1 strain
among injection drug users (IDUs) in Taiwan. It contains a 7 amino-acid deletion in
its p6
gag. We conducted a cohort study to compare viral loads and CD4 cell count
changes between patients infected with subtype B and CRF07_BC and to elucidate
its mechanism. Twenty-one patients infected with CRF07_BC and 59 patients with
subtype B were selected from a cohort of 667 HIV-1/AIDS patients whom have
been followed up for 3 years. Generalized estimated equation was used to analyze
their clinical data and the results showed that patients infected with CRF07_BC had
significantly lower viral loads (about 58,000 copies per ml less) than patients with
subtype B infection (p50.002). The replicative capacity of nine CRF07_BC and four
subtype B isolates were compared and the results showed that the former had
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PLOS ONE | DOI:10.1371/journal.pone.0114441 December 11, 2014 1/1 9significantly lower replicative capacity than the latter although all of them were
CCR5- tropic and non-syncytium inducing viruses. An HIV-1-NL4-3 mutant virus
which contains a 7 amino-acid deletion in p6
gag (designated as 7d virus) was
generated and its live cycle was investigated. The results showed that 7d virus had
significantly lower replication capacity, poorer protease-mediated processing and
viral proteins production. Electron microscopic examination of cells infected with
wild-type or 7d virus demonstrated that the 7d virus had poorer and slower viral
maturation processes: more viruses attached to the cell membrane and higher
proportion of immature virions outside the cells. The interaction between p6
gag and
Alix protein was less efficient in cells infected with 7d virus. In conclusion, patients
infected with CRF07_BC had significantly lower viral loads than patients infected
with subtype B and it may due to the deletion of 7 amino acids which overlaps with
Alix protein-binding domain of the p6
gag.
Introduction
Understanding the factors affecting AIDS disease progression is very important
for clinical management and counseling. It has been reported that HIV-1 patients
infected with different subtypes have different rates of disease progression [1–3].
In Kenya, patients infected with subtype D recombinant virus had significantly
faster disease progression than patients infected with subtype A in spite that they
had similar viral loads [2]. A meta-analysis indicated that the trend of disease
progression among different HIV-1 subtype in a descending order was subtype
C.D.AE.G.A[ 4].
By the end of 2013, 27,366 individuals (including 891 foreigners) were reported
as infected with HIV-1 by the Taiwan’s Centers for Disease Control (CDC). Risk
factor analyses showed that more than 50% of the HIV-1/AIDS patients were men
who have sex with men (MSM) and about 25% were injection drug users (IDUs)
[5]. In terms of subtype distribution, subtype B, CRF01_AE and CRF07_BC were
predominant in MSM, heterosexuals, and IDUs respectively [6–10]. There are an
estimated 60,000 to 100,000 IDUs in Taiwan and about 15% of them are infected
with HIV-1 [9]. Since 83% of those HIV-1-infected IDUs may be infected with
CRF07_BC [10], the numbers of IDUs in Taiwan who may be infected with
CRF07_BC are between 7,470–12,450. Therefore, it is very important to
understand the natural history and disease progression of CRF07_BC infection.
Previously, our full-length sequencing results indicated that all the Taiwanese
CRF07_BC strains contain a signature 7 amino-acid deletion in p6
gag [8]. The
p6
gag contains two motifs- PTAP and YPXnL (X can vary in sequence) which are
important for viral assembling and budding. YPXnL motif is located between
amino acid residues 36 and 44 at its C-terminal region and it interacts with AIP1
(apoptosis-linked gene 2-interacting protein, also known as Alix) [11,12]. Since a
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that such deletion may affect the viral life cycle, especially during virus assembly.
In this study, 21 patients infected with CRF07_BC and 59 patients with subtype B
were selected from a cohort of 667 HIV-1/AIDS patients whom have been
followed up for more than 3 years. A GEE model was used to analyze multiple
time points data and demonstrated that patients with CRF07_BC infection had
significantly lower viral loads than patients with subtype B infection and it was
mainly associated with the viral subtypes. Subsequently, we used both clinical
isolates and molecular clones with specific deletion of those 7 amino-acid from
p6
gag to elucidate the mechanism and the results indicated that the lower
replication capacity, poorer protease-mediated processing and viral proteins
production of CRF07_BC were due to a 7 amino-acid deletion in its p6
gag domain.
Methods
Patient Cohort and Study Design
In 2010, we established Taiwan HIV-1 Observational Database (TwHOD) to study
the natural history and clinical aspects of Taiwanese HIV-1/AIDS patients. The
TwHOD is a collaborative cohort study that involves the following hospitals
located in the northern region (Taipei Veterans’ General Hospital, Far Eastern
Memorial Hospital, and Taipei City Hospital), central region (Taichung Veterans’
General Hospital) and southern region (Kaohsiung Veterans’ General Hospital) of
Taiwan. The study was approved by the Institutional Review Boards (IRB) of all
the participating hospitals. Written informed consent was obtained from patients
who agreed to participate in this study. The procedure of data collection was
similar to that reported by TREAT Asia HIV-1 Observational Database [13]. By
the end of 2012, 667 HIV-1/AIDS patients enrolled in this study and the HIV-1
subtypes of 272 patients were determined. For the nested case control study, we
selected 21 male treatment naı ¨ve patients infected with CRF07_BC and matched
them with 59 subtype B-infected patients by gender, age and risk factor. Eleven
patients who were infected with CRF07_BC were excluded due to gender (3 were
female patients), previous antiretroviral therapy (2 patients) or lack of CD4 cell
count or viral loads data (6 patients).
Subtyping and Isolation of HIV-1 viruses
HIV-1 subtypes were determined as described previously [14]. Nine CRF07_BC
and 4 subtype B strains from treatment-naı ¨ve IDUs were obtained by using
standard peripheral blood mononuclear cells (PBMCs) co-culture methods [15].
We enrolled treatment naı ¨ve HIV-1-infected IDU patients with CD4 cell counts of
more than 500 cells/mm
3. Initially, we selected 10 treatment naı ¨ve patients with
CRF07_BC and 5 patients with subtype B infection for the virus isolation
experiments. Eventually, 9 CRF07_BC and 4 subtype B isolates were obtained.
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Ability
Chemokine co-receptor usage and the SI ability were determined as described
previously [16,17]. In terms of sequence analysis of V3 region of env gene, co-
receptor usage was determined as described previously [18–20].
Generation of Recombinant Viruses
To generate HIV-1 infectious recombinant viruses with or without a 7 amino-acid
deletion at its p6
gag, MT2 cells were co-transfected with a linear marker plasmid
pNL43HIVDPR.RTBstEIInef-GFP and one of two linear plasmids pGEM-NCRT
or pGEM-NCRT-7d using an electroporation method [21]. Briefly, a 1,652-bp
fragment encompassing the coding regions of HIV-1 nucleocapsid protein-p6-
protease-reverse transcriptase was amplified from plasmid pNL4-3 (correspond-
ing to nucleotides 1827 to 3649 of the HIV-1 NL4-3 sequence) using PCR. It was
sub-cloned into pGEM-T vector (Promega, Madison, Wisconsin) to generate a
plasmid designated as pGEM-NCRT. Subsequently, we used PCR-based site-
directed mutagenesis to delete nucleotide sequences 2220–2240 of HIV-1 NL4-3
to generate a plasmid containing a 7 amino-acid deletion in its p6
gag (pGEM-
NCRT-7d).
Growth Kinetic Assay
Growth kinetic of primary isolates and infectious recombinant viruses were
measured in PBMCs and MT2 cells, respectively and described with some
modifications [17]. Cells were plated in 24-well plates at 10
6 cells/well in 1 ml of
RPMI 1640 medium, and 3,000 50% tissue culture infective dose (TCID50)o f
HIV-1 viruses were added. The cultures were split every 3-4 days by replacing 50%
of the culture with the same volume of fresh medium and p24 quantified as a
measure of ongoing virus replication. Growth kinetic of infectious recombinant
viruses was measured in MT2 cells, as described elsewhere [17] with modification.
A total of 2610
6 cells were infected with 2,000 TCID50 of viruses. After
incubation for 2 hours at 37˚C, cells were washed twice with phosphate-buffered
saline (PBS) and resuspended in RPMI 1640 medium. Triplicate cultures were
tested, and viral growth was determined by HIV-1 p24 levels on days 2, 4, 6, 8, 10,
12 and 14. HIV-1 p24 antigen determined by enzyme-linked immunosorbent
assay (ELISA) (PerkinElmer, Waltham, USA) was considered an indicator of virus
replication.
Western Blot (WB) Assay
The details of WB have been described previously [22]. HIV-1 Gag proteins were
detected by anti-p24
gag mouse monoclonal antibody (clone 183-H12-5C) [23]. RT
was detected by anti-RT mouse monoclonal antibody [24]. Protease was detected
by anti-HIV protease mouse monoclonal antibody (Abcam). The bound antibody
The Secret of Low Viral Load of CRF07_BC
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secondary antibody (Amersham Corp.). Image J software (version 1.47) was used
to analyze the intensity of reactive bands in WB.
Electron microscopy
Infected MAGIC-5 cells [25] were fixed in 2.5% glutaraldehyde-0.2M sodium
cacodylate solution overnight at 4˚C, and then fixed with 1% OsO4 in PBS for
1.5 hours. Specimens were then dehydrated in graded ethanol solution and
embedded in Epon. Ultrathin sections were stained with uranyl acetate and lead
citrate, and images were obtained using Jeol JEM-2000EXII transmission electron
microscope (TEM).
Indirect Immunofluorescent Antibody (IFA) Staining and Total
Internal Reflection Fluorescence (TIRF)
To detect and quantify the interaction between p6
gag and Alix, IFA staining with
TIRF and super-resolution fluorescence localization imaging methods were used
(Leica SR GSD) [26,27] for immunostaining, Gag was detected by anti-p24
Gag
mouse monoclonal antibody. Alix was detected by anti-Alix rabbit polyclonal
antibody. The secondary antibodies were anti-mouse and anti-rabbit fluorescence
(Alexa 488 and Alexa 647)-conjugated antibodies. Phosphate buffered saline
containing 100 mM b-mercaptoethylamine (MEA) was used for SR fluorescence
localization imaging. Imaging fields were magnified using a 1006 oil objective
(Leica) with a 1.47 numerical aperture and 1.66 optical magnification. The
penetration depth of the excitation laser source for TIRF and super-resolution
imaging was 200 nm. TIRF fluorescence image stacks consisting of over 30,000
frames were used to calculate SR fluorescence images. A two-dimensional spatial
histogram map in each fluorescence channel was calculated using the SR images
with an effective pixel size of 20 nm. The co-localization coefficients of two
proteins were quantified by a combination of Manders analysis and two-
dimensional spatial histogram maps of two fluorescence channels, with the
fluorescence background removed during intensity-based co-localization analysis.
Statistical Analysis
A multivariate linear generalized estimating equations (GEE) model was
performed to identify factors associated with the changes of CD4 cell count or
viral loads. One-way ANOVA and Tukey’s post hoc test were used to compare the
p24 antigen levels between different subtypes or infectious recombinant viruses.
SAS statistic software (SAS version 9.1; SAS Institute, Cary, North Carolina, USA)
was used with significance level set at p,0.05.
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Study Population Characteristics
In total, 667 HIV-1/AIDS patients were recruited in this study. The median
follow-up period was 46 months. In terms of socio-demographic variables, the age
of the participants ranged from 15 to 81 years at diagnosis of HIV-1 infection. The
median age was 31 years and 94.0% were men. The majority of the patients were
MSM (388/600 [64.7%]) and 22.5% were IDUs. The results of HBsAg and HCV
antibody tests were available for 301 (45.1%) and 388 (58.2%) patients,
respectively. Seventy-one (23.6%) patients were HBsAg positive and 121 patients
(31.2%) had anti-HCV antibodies. There were 466 patients (69.9%) under ART
(Table 1).
Among 272 patients whose subtypes have been determined using nested
multiplex PCR, 80.5% were subtype B, 11.8% CRF07_BC, and 6.3% CRF01_AE.
Three (1.1%) patients infected with subtype C and one patient with CRF08_BC
(0.4%) (Table 1). Subtype B was predominant in MSM (93.9%) and heterosexuals
(69.9%). 74.3% of IDUs were infected with CRF07_BC. Notably, two MSMs were
infected with CRF07_BC and they denied using intravenous drugs before. In
addition, we found that there was one MSM infected with CRF08_BC and three
MSM infected with subtype C (Table 2).
Factors Affecting Disease Progression
As shown in Figs. 1A and 1B, compared with MSM, IDUs had consistently higher
CD4 cell count and lower HIV-1 viral loads over 2.5 years. A GEE model was used
to identify factors associated with changes of CD4 cell count or viral loads. The
variables which potentially may influence the CD4 cell count or HIV-1 viral loads
were considered in this analysis. As shown in Table 3, regardless of whether
‘‘mode of infection’’ was added in the model (multivariate model I vs. model II),
factors significantly associated with CD4 cell count changes included older age,
subtypes (CRF01_AE and CRF08_BC), higher viral loads and no previous
HAART. In contrast, when we analyzed factors associated with changes of viral
loads, once we deleted ‘‘mode of infection’’ from the model (multivariate model
II), we found that CRF07_BC infection became significantly associated with lower
viral loads compared to subtype B infection (Table 4).
To evaluate the effect of HIV-1 subtypes on CD4 cell count and HIV-1 viral
loads, a nested case control study which consisted of 21 patients with CRF07_BC
infection and 59 patients with subtype B infection was established. They were all
treatment-naı ¨ve patients and matched by age and gender. The results showed that
there was no significant difference in CD4 cell count (GEE model, p50.168)
(Fig. 1C). In contrast, patients infected with CRF07_BC had significantly lower
viral loads than patients infected with subtype B (GEE model, p50.002) (Fig. 1D).
The Secret of Low Viral Load of CRF07_BC
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Subtype B Isolates
To confirm the findings mentioned above, we used co-culture methods to isolate
CRF07_BC and subtype B strains from clinical specimens to compare their
replication capacity. The results showed that the replication capacity of 9
Table 1. Demographic data, risk factors and clinical characteristics of HIV-1-infected patients recruited in the study.
HIV-1 infected population
Male (%) Female (%) Total (%)
(N5627) (N540) (N5667)
Age (yrs) n5612 n537 n5649
15–29 287 (46.9) 12 (32.4) 299 (49.2)
30–50 283 (46.2) 19 (51.4) 302 (42.5)
$50 42 (6.9) 6 (16.2) 48 (8.3)
Mode of infection n5561 n539 n5600
Homosexual contact 388 (69.2) 0 (0) 388 (64.7)
Heterosexual contact 51 (9.1) 20 (51.3) 71 (11.8)
Injecting drug use 116 (20.7) 19 (48.7) 135 (22.5)
Receipt of blood products 6 (1.1) 0 (0) 6 (1.0)
HBV coinfection n5280 n521 n5301
HBsAg, positive 68 (24.3) 3 (14.3) 71 (23.6)
HCV coinfection n5361 n527 n5388
HCVAb, positive 105 (29.1) 16 (59.3) 121 (31.2)
Antiretroviral treatment n5627 n540 n5667
HAART 444 (70.8) 22 (55.0) 466 (69.9)
HIV-1 subtype n5262 n510 n5272
B 215 (82.1) 4 (40.0) 219 (80.5)
C 3 (1.1) 0 (0) 3 (1.1)
CRF01_AE 14 (5.3) 3 (30.0) 17 (6.3)
CRF07_BC 29 (11.1) 3 (30.0) 32 (11.8)
CRF08_BC 1 (0.4) 0 (0) 1 (0.4)
doi:10.1371/journal.pone.0114441.t001
Table 2. Distribution of HIV-1 subtypes and circulating recombinant forms (CRFs) in different groups of patients recruited in this cohort study.
Male
Subtype/CRF Heterosexual MSM IDUs Others Female
a Total
B 16 (69.6) 154 (93.9) 9 (25.7) 36 (90.0) 4 (40) 219 (80.5)
C 0 (0) 3 (1.8) 0 (0) 0 (0) 0 (0) 3 (1.1)
CRF01_AE 7 (30.4) 4 (2.4) 0 (0) 3 (7.5) 3 (30) 17 (6.3)
CRF07_BC 0 (0) 2 (1.2) 26 (74.3) 1 (2.5) 3 (30) 32 (11.8)
CRF08_BC 0 (0) 1 (0.6) 0 (0) 0 (0) 0 (0) 1 (0.4)
Total 23 (100) 164 (100) 35 (100) 40 (100) 10 (100) 272 (100)
aIncludes 4 heterosexual female infected with subtype B, 3 heterosexual female infected with CRF01_AE, and 3 IDUs infected with CRF07_BC.
doi:10.1371/journal.pone.0114441.t002
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(Fig. 2A). As shown in Fig. 2B, CRF07_BC isolates had significantly lower
replication capacity than subtype B isolates.
Both Subtype B and CRF07_BC Isolates were CCR5-tropic and
Non-syncytia Inducing
Both genotypic and phenotypic assays were employed to compare the tropism
between subtype B and CRF07_BC. In the genotypic assay, the C2-V5 regions of
the env from 10 isolates were amplified using RT-PCR and the deduced amino
Fig. 1. Comparisons of the changes of CD4 cell count and HIV-1 viral loads after the first clinical visit among the following four groups of
treatment naı ¨ve patients. Men who have sex with men (MSM, 357 patients for CD4 cell count and 371 patients for viral loads analysis) vs. injection drug
users (IDUs, 129 patients for CD4 cell count and 128 patients for viral loads analysis) (Fig. 1A and 1B); patients infected with CRF07_BC vs. infected with
subtype B (Figs. 1C and 1D). A generalized estimating equation model was used for the analyses.
doi:10.1371/journal.pone.0114441.g001
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CRF07_BC isolates contained the typical GPGQ motif. Two of the three subtype B
isolates had an amino acid deletion at position 25 of the V3 loop and all subtype B
strains had the GPGR/K motif. Based on the 11/25 rule (presence of basic amino
acid at positions 11 and 25 are X4 viruses) and the results from online tropism
prediction (Geno2pheno and PSSM prediction programs), we concluded that all
isolates were CCR5 tropic viruses. In the phenotypic prediction assay, results
indicated that all isolates were R5 tropism and non-syncytium inducing (NSI)
(Table 5).
Table 3. Univariate and multivariate generalized estimating equations models of factors associated with CD4 cell counts.
Univariate Multivariate model I Multivariate model II
a
No. difference p difference p difference p
Gender
Male 578
Female 37 20.8 0.541 43.0 0.187 52.2 0.082
Age (yrs)
15–29 271
30–50 281 231.1 0.084 243.6 0.012 236.4 0.040
$50 46 2153.2 ,0.001 2140.6 ,0.001 2170.7 ,0.001
Mode of transmission
Homosexual contact 357
Heterosexual contact 70 259.8 0.032 233.9 0.228 - -
Injecting drug use 129 40.7 0.066 103.3 0.001 - -
Receipt of blood products 6 2164.4 0.115 2118.5 0.222 - -
HIV-1 subtype
B 201
C 3 85.6 0.317 68.2 0.384 70.5 0.367
CRF01_AE 15 2147.7 0.004 2103.3 0.041 2118.0 0.020
CRF07_BC 31 9.9 0.746 224.4 0.510 53.1 0.084
CRF08_BC 1 2225.6 ,0.001 2132.3 ,0.001 2135.5 ,0.001
HIV viral loads (copies/ml)
,40 225
40–400 34 242.8 0.008 244.1 0.007 241.4 0.010
401–10,000 93 2107.1 ,0.001 299.0 ,0.001 297.7 ,0.001
.10,000 109 2169.9 ,0.001 2151.2 ,0.001 2153.6 ,0.001
Received ART
No 261
Yes 354 118.3 ,0.001 50.0 0.005 41.6 0.020
aThe mode of transmission was removed from multivariate model II.
doi:10.1371/journal.pone.0114441.t003
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gag on Viral Life Cycle
Since co-receptor usage and SI properties of subtype B and CRF07_BC isolates are
similar, we further studied the effect of a 7 amino-acid deletion of p6
gag on the
viral life cycle. We generated HIV-1 NL4-3 recombinant virus containing a 7
amino-acid deletion in the p6
gag (7d virus). The replication capacity was analyzed
by infecting MT-2 cells with wild-type (wt) and 7d viruses. Results showed that 7d
virus replicated significantly slower than the wt virus (Fig. 2C).
To compare the efficiency of protease-mediated Gag processing and viral
protein production in the wt and 7d viruses, we analyzed the reactive intensity of
different protein bands in the viral lysates at 12, 24, 36 and 48 hours post-
infection using WB assay. As shown in Fig. 3, compared to the wt virus, the level
of viral proteins of 7d virus including p24, RT and PR appeared much lower in the
cell lysates (24, 36 and 48 hours post-infection) and viral lysates (36 and 48 hours
Table 4. Univariate and multivariate generalized estimating equations model of factors associated with HIV-1 viral loads.
Univariate Multivariate model I Multivariate model II
a
No. difference p difference p difference P
Gender
Male 603
Female 38 226767.8 ,0.001 220826.2 0.013 226658.9 ,0.001
Age (yrs)
,30 286
30–50 290 24936.2 0.449 1520.8 0.823 23313.5 0.633
$50 48 24747.7 0.627 2665.1 0.802 8246.7 0.404
Mode of transmission
Homosexual contact 371
Heterosexual contact 70 23605.2 0.706 10465.9 0.387 - -
Injecting drug use 128 222329.5 ,0.001 273432.1 ,0.001 - -
Receipt of blood products 6 27205.5 0.752 235456.4 0.227 - -
HIV-1 subtype
B 217
C 3 1607.7 0.940 23058.5 0.269 19596.9 0.325
CRF01_AE 16 210620.5 0.291 243785.9 0.004 237612.3 0.004
CRF07_BC 30 221153.8 0.005 29074.4 0.472 258045.6 ,0.001
CRF08_BC 1 27883.3 0.086 2113409.7 ,0.001 2106777.7 ,0.001
CD4 cell count (cells/mm
3)
#50 22
51–250 82 2263241.1 ,0.001 2240696.2 ,0.001 2246030.4 ,0.001
251–500 209 2313911.1 ,0.001 2290801.3 ,0.001 2296881.6 ,0.001
.500 160 2334294.9 ,0.001 2300993.4 ,0.001 2309618.0 ,0.001
Received ART
No 270
Yes 371 297661.2 ,0.001 2102574.2 ,0.001 288088.5 ,0.001
aThe mode of transmission was removed from multivariate model II.
doi:10.1371/journal.pone.0114441.t004
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of 7d virus in the viral lysates was significantly lower than those of the wt virus at
48 hours post-infection (Fig. 3B). Furthermore, we calculated the viral matura-
tion index (the ratio of p24 to Pr55 in viral lysates) and found that 7d virus had
significantly lower maturation index than the wt virus (Fig. 3C).
We also used electron microscopy to compare the morphogenesis between wt
and 7d virions. We collected MAGIC-5 cells at different time points after infection
with equal amounts of wt and 7d viruses and performed TEM. Results showed
that more budding virions were observed in cells infected with wt virus than 7d
Fig. 2. Comparison of the replication kinetics of different HIV-1 isolates from patients infected with CRF07_BC or subtype B (A and B) as well as
recombinant HIV-1 virus with or without a 7 amino-acid deletion in the p6
gag protein. (A) PBMCs were infected with fixed amounts of different HIV-1
subtype B (square) or CRF07_BC (circle) isolates and cultural supernatants were collected at days 4, 7, 11, 14, 18 and 21 post-infection. (B) The
representative replicative curves of CRF07_BC and subtype B isolates deduced from Fig. 2A. (C) MT2 cells were infected with wild type (wt) or recombinant
mutant virus with a 7 amino-acid deletion at the p6
gag (7d). Supernatants were collected at days 2, 4, 6, 8, 10, 12, and 14 post-infection. Viral replication was
monitored through p24 antigen production. One-way analysis of variance (ANOVA) and Tukey’s post hoc test were used to estimate the differences between
subtypes, or between the recombinant viruses.
doi:10.1371/journal.pone.0114441.g002
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from cell membranes was found in cells infected with 7d virus at different time
points (Fig. 3E).
Since the 7 amino-acid deletion overlaps with the Alix binding domain of p6
gag,
we conducted IFA staining with anti- p24
Gag and anti-Alix antibodies and
analyzed their interaction using confocal microscopic exam with super-resolution
program. The results showed that the co-localization coeffcicent of Gag and Alix
was significantly lower in 7d virus than in wt virus (36.4% versus 48.88%,
p,0.05) (Fig. 4).
Discussion
Previously, several studies demonstrated that compared with patients infected
with subtype B, patients infected with CRF01_AE had faster disease progression
[28,29]. While studies have compared the viral loads of patients with different
subtypes including CRF01_AE, this study was the first to conduct a comparison of
viral loads between patients infected with subtype B and CRF07_BC. We
conducted a nested case control study using an HIV-1/AIDS patient cohort which
we have followed up since 2010 to demonstrate that patients infected with
CRF07_BC had significantly lower viral loads (about 58,000 copies/ml in average)
than patients with subtype B infection (Table 4 and Fig. 1D). We also found that
gender, HIV-1 subtype, CD4 cell count and ART were strongly associated with
viral loads. Furthermore, a GEE model was performed to compare viral load
differences in treatment naı ¨ve patients infected with subtype B and CRF07_BC at
Table 5. V3 amino acid sequences and predicted phenotypes of different HIV-1 isolates in Taiwan.
Isolate
Consensus V3 region amino acid sequences 11 1819
232425 CTRPNNNTRKSIHIGPGRAFYTTGEIIGDIRQAHC
Genetic
subtype Biotype
MT-2
assay Predictions
Sequence
a Geno2pheno
b PSSM
c
TW_D78 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D83 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D590 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D592 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D848 CTRPGNNTRKSIRIGPGQTFYATGEIIGNIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D854 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D855 CTRPGNNTRKSIRIGPGQTFYATGDIIGDIRQAHC CRF07_BC R5 NSI R5 R5 R5
TW_D40 CTRPNNNTRRSIPIGPGRAFYTSE-IIGDIRKAHC B R5 NSI R5 R5 R5
TW_D257 CTRPNNNTRKSISMGPGKAFFATGDIIGDIRAAYC B R5 NSI R5 R5 R5
TW_D573 CTRPNNNTRKSIPIGPGRAFYTTN-IIGDIRKAHC B R5 NSI R5 R5 R5
A dash indicated a deletion or lack of an insertion.
aThe phenotype prediction based on 2 amino acid insertion/deletion between position 14 and 15, as well as variable amino acid positions (11, 18, 19, 23, 24
and 25) of V3 regions.
bGeno2pheno (http://coreceptor.bioinf.mpi-inf.mpg.de/index.php), false-positive rate of 0.01.
cPosition-Specific Scoring Matrix (PSSM) (http://indra.mullins.microbiol.washington.edu/webpssm/).
doi:10.1371/journal.pone.0114441.t005
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gag to the HIV-1 proteins expression, release and maturation. MT2 cells were
infected with wild type (wt) or deleted-type (7d) recombinant viruses. After 12, 24, 36 and 48 hours, supernatant was collected and pelleted by
ultracentrifugation. (A) Western blot analysis of the cell lysates (left panel) and viral lysates (right panel) from cells infected with wt or 7d viruses. (B) The
relative expression levels of PR and RT in the viral lysates of cells infected with wt or 7d virus. The total arbitrary densitometer units of PR and RT were
standardized by p24 and normalized to those of wt in parallel experiments. The images were analyzed with Image J software. (C) The ratios of p24 vs. Pr55
(maturation index) in the viral lysates at different time points after infection were calculated. The total arbitrary densitometer units of each hours post infection
were normalized to those of wt in parallel experiments. All results were representative of two independent experiments. (D) Electron microscopic (EM)
examination of the viral particles of cells infected with wt or 7d recombinant viruses. MAGIC-5 cells were fixed and processed for transmission EM at
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gender and initial CD4 cell count. The results showed that when we matched the
cases by initial CD4 cell count, the viral loads of patients infected with CRF07_BC
were consistently lower than those patients with subtype B (Fig. 1D). The GEE
model has been widely used to estimate the parameters of a generalized linear
model with a possible unknown correlation between outcomes [30]. Since the
focus of the GEE is on estimating the average response over the population rather
than the regression parameters that would enable prediction of the effect of
changing one or more covariates on a given individual, it can be used to
determine the association between multiple time points of plasma viral loads or
CD4 cell counts in patients and model the association between factors [31–33].
Previous studies demonstrated that male, older age and fast CD4 cell count
depletion were significantly associated with higher viral loads [34,35]. Variable
disease progression rates among individuals infected with HIV-1 have been
recognized, and different factors influencing clinical outcome have been
demonstrated, including host genetic, immunological and virological aspects [36].
Examples of host factors include human leukocyte antigens (HLA) and
chemokine co-receptor genotype, as well as the age of the individual at the time of
infection. Virological characteristics have also been shown to affect pathogenicity,
such as HIV-1 subtypes, chemokine co-receptor use, syncytium-forming
properties, and viral fitness [1–3,37]. Since plasma viral loads have been shown to
be the best prognostic marker for disease progression, our data suggests that
different time points after they were infected with wt or 7d viruses. Scale bar indicates 200 nm. (E) Quantification of relative proportions of mature vs.
immature virions released at different time points in the cells infected with wt or 7d viruses using EM. The method of virion quantification has been described
previously [43].
doi:10.1371/journal.pone.0114441.g003
Fig. 4. The interaction between Alix protein and wild type/mutant Gag. MAGIC-5 cells were infected
with wt or 7d recombinant virus for 48 hours. The Alix and Gag proteins were analyze by TIRF-SR with
rabbit anti-Alix polyclonal antibody and mouse anti-p24 monoclonal antibody. Red spots indicate Alix protein.
Green spots indicate either wild type or 7d Gag protein. The proportion of co-localization of Alix and Gag
protein was quantified using Volocity 3D Image Analysis Software.
doi:10.1371/journal.pone.0114441.g004
The Secret of Low Viral Load of CRF07_BC
PLOS ONE | DOI:10.1371/journal.pone.0114441 December 11, 2014 14 / 19patients infected with CRF07_BC may have a much slower disease progression
rate than patients infected with subtype B [38].
We performed growth kinetic analysis to compare subtype B and CRF07_BC
primary isolates. CRF07_BC, as well as infectious recombinant viruses carrying a 7
amino-acid deletion in p6
gag, showed significantly reduced replication capacity
(Fig. 2). The data presented here indicated that CRF07_BC was associated with
slower clinical progression in treatment naı ¨ve HIV-1/AIDS patients. Previously,
several studies have demonstrated that the different rates of disease progression
strongly correlated with different HIV-1 subtypes [1,2]. The different co-receptor
usage of HIV-1 can affect replication rate. In general, NSI virus (or R5 virus)
replicates more slowly than SI virus (or X4 virus) [39]. Our data indicated that the
all the Taiwanese CRF07_BC isolates tested were NSI and replicated in CCR5-
expressing cells. Furthermore, we found that CRF07_BC strains showed patterns
of moderate-level replication compared with subtype B in PBMCs. We suggest
that the reason may be that the genome in CRF07_BC strains was mostly subtype
C with only five regions from subtype B [8]. However, subtype C infected patients
are extreme rare in Taiwan. It is difficult to compare the disease progression
between CRF07_BC and subtype C infected patients in Taiwan. Previous studies
showed that R5-tropic subtype C strains replicate more slowly in PBMCs than R5-
tropic subtype B strains in vitro growth competition assays [40].
The 7 amino-acid deletion (residues 30 to 36) is quite unique to CRF07_BC.
We previously reported that the 7 amino-acid deletion is unique among almost all
the CRF07_BC strains isolated in Taiwan. One Taiwanese CRF07_BC strain even
had a 11 amino-acid deletion in the p6
gag protein [8]. Subsequently, YM Shao’s
group sequenced 66 CRF07_BC strains from mainland China and found that the
deletion was present in 25.8% of the cases [41]. As for whether other subtypes of
CRFs have such deletion, according to our preliminary results using Los Alamos
National Laboratory HIV-1 sequence database (http://hiv-web.lanl.gov) and data
from YM Shao’s paper, none of HIV-1 subtypes B, C CRF08_BC and other BC
recombinants have this 7 amino-acid deletion [8]. In this study, we found that
p6
gag containing a 7 amino-acid deletion showed moderate to severe defects in
Gag processing and fewer viral enzymatic proteins in infected cell and virions
(Fig. 3). HIV-1 protease-mediated gag processing and gag protein interaction
with host cell proteins are very important for virus assembly, budding and
maturation [42]. Tsg101 binding domain of HIV-1 p6
gag region (PTAP) was
highly conserved in all the Taiwanese CRF07_BC strains, but they all have a 7
amino-acid deletion which overlaps with Alix binding domain (36-YPLASLRSL-
44) at the residue 36Y [8]. A previous study demonstrated that Y36A mutation in
p6
gag protein was critical for Alix interaction and virus budding [43]. HIV-1
release forms a viral bud and the connection between the membrane bud and
plasma membrane needs to be disassociated [44]. In this study, we found that co-
localization coefficient between Gag and Alix was significantly lower in 7d virus
(Fig. 4). We therefore suggest that such deletions in p6
gag may affect its binding
with Alix and subsequently affect virus release. In addition, Gag-Pol proteins are
translated by -1 ribosomal frame shift during Gag translation [45]. Within the
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gag is truncated and replaced by a trans-frame domain referred to
as p6
pol [46]. Deletions or mutations of p6
pol affect p6
pol-PR disassociation and
further impair PR activity [47]. Chiu et al performed a single – cycle infection
assay and demonstrated that p6
pol deletion affected viral infectivity and reduced
the p24/Pr55 protein ratio. [22]. A previous study demonstrated that truncation
of p6
gag reduced the amount of viral enzymatic proteins in the virions [48].
Furthermore, our data showed that the 7 amino-acid deletion in p6
gag domain
affected Gag processing efficiency and the amount of viral enzymatic proteins in
HIV-1 virions. Further studies are needed to elucidate whether p6
pol containing a
7 amino-acid deletion affects the incorporation of gag-pol into virus particle or
virus assembly in the nearby cytoplasmic membrane.
This is the first study that combines a longitudinal clinical follow-up study and
a virological characterization of CRF07_BC infection. The Taiwanese CRF07_BC
strains have about 97% nucleotide sequence homology with the prototypic
CRF07_BC strains in China [8]. According to our previous phylogenetic analysis
using the env gene, the Taiwanese CRF07_BC strains collected in 2004 formed at
least two clusters with bootstrap value of 71 [8]. This phenomenon was
reconfirmed by analysis of a larger number of CRF07_BC strains collected
between 2005-2008, which showed a bootstrap value of 80 [10]. Therefore, there
were more than 1 wave of CRF07_BC infection being transmitted to Taiwan and
we believe that the findings in this study can also be applied to the CRF07_BC
strains in mainland China.
In conclusion, our results suggest that patients infected with CRF07_BC have
slower rate of disease progression and the deletion of 7 amino acids in its p6
gag
region plays an important role in the assembly, budding and maturation processes
of the viral life cycle.
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